FriendnPal
PrivateLast Round
Pre Seed
Dec 1, 2025
Est. Valuation
$2M
Total Funding Raised
$25,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
FriendnPal operates in Healthcare & Life Sciences and is based in Enugu. Its latest recorded funding round was an Accelerator round in October 2024.
FriendnPal is a digital health company that provides an AI-powered, multilingual mental health platform offering therapy, counseling, and peer support services tailored to African communities.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, NLP & Conversational AI, Healthcare Analytics, Patient Engagement
Business Model
B2C
Customer Profile
Freemium, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FriendnPal Comparables
Compare FriendnPal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nguvu Health | 85% | |
| SereniMind | 84% | |
| MyTherapist.ng | 84% |
For institutional investors. Book with your work email.
FriendnPal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Dec 1, 2025 | ||||
| Accelerator | Oct 9, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FriendnPal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Resilience17 | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
$500K raised in Pre Seed round
- Sep 3, 2025
Grew 15% QoQ, from 53 to 61 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 21, 2026
In Nigeria, Friendnpal is building an AI-powered mobile therapy service that uses multimodal AI, behavioural analytics, clinical assessments and human clinical triage to detect mental health risks earlier and deliver continuous care; the platform supports mobile, web, voice and WhatsApp access in more than 50 languages as of Sep 21st '26.
- is_developingSep 21, 2026
On Sep 21st '26 in Nigeria, Friendnpal is building an AI-powered behavioural health intelligence and remote patient monitoring platform that detects mental health risks earlier, supports earlier intervention, and delivers continuous care through mobile, web, voice, and WhatsApp.
For institutional investors. Book with your work email.
FriendnPal Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FriendnPal's valuation, stock price, and market status.
Is FriendnPal a public or private company?
FriendnPal is a private company.
What is the current stock price of FriendnPal?
FriendnPal is a private company, so its shares have no public market price. Caplight tracks FriendnPal's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FriendnPal worth (valuation)?
FriendnPal's valuation is estimated at $2.0M based on funding round data.
Can I buy FriendnPal stock?
FriendnPal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FriendnPal's last funding round?
FriendnPal's most recent funding round was Pre Seed on December 1, 2025.
Who are the main investors in FriendnPal?
Key investors in FriendnPal include Resilience17.
Will FriendnPal IPO soon?
No public IPO plans have been announced for FriendnPal.
How can I track FriendnPal secondary market activity?
Caplight tracks bids, offers, and trades in FriendnPal's shares on secondary markets.